TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 10 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,000 | -33.3% | 167 | -33.2% | 0.00% | – |
| Q4 2021 | $3,000 | -25.0% | 250 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $4,000 | 0.0% | 250 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $4,000 | -20.0% | 250 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $5,000 | 0.0% | 250 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $5,000 | 0.0% | 250 | -14.1% | 0.00% | 0.0% |
| Q3 2020 | $5,000 | 0.0% | 291 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $5,000 | +25.0% | 291 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $4,000 | +300.0% | 291 | +369.4% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 62 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | -75.0% | 62 | -67.9% | 0.00% | -100.0% |
| Q1 2019 | $4,000 | +100.0% | 193 | +70.8% | 0.00% | 0.0% |
| Q3 2018 | $2,000 | -50.0% | 113 | -42.3% | 0.00% | 0.0% |
| Q2 2018 | $4,000 | +33.3% | 196 | +76.6% | 0.00% | 0.0% |
| Q1 2018 | $3,000 | – | 111 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 7,584,930 | $138,046,000 | 26.79% |
| Glenview Capital Management | 15,260,512 | $277,741,000 | 6.37% |
| Paulson & Co. | 11,295,846 | $205,584,000 | 5.34% |
| GMT CAPITAL CORP | 2,871,395 | $52,259,000 | 3.72% |
| MANAGED ASSET PORTFOLIOS, LLC | 966,643 | $17,593,000 | 3.09% |
| TFG Asset Management GP Ltd | 1,443,052 | $26,264,000 | 1.76% |
| Mondrian Investment Partners LTD | 3,274,660 | $58,944,000 | 1.46% |
| Blackcrane Capital, LLC | 35,236 | $641,000 | 1.26% |
| Lumbard & Kellner, LLC | 136,378 | $2,404,000 | 0.95% |
| DAVIDSON INVESTMENT ADVISORS | 509,800 | $9,278,000 | 0.86% |